Clinical Trial Update: Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism [NA]

View source ↗

Summary

A clinical trial evaluating whether a zinc, selenium, and L-tyrosine supplement can prevent thyrotoxicosis in people with the SEPP1 polymorphism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyrotoxicosis

Drugs mentioned

• Zinc, Selenium, and L-Tyrosine supplement

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Thyrotoxicosis | NA | Status: NOT_YET_RECRUITING